Differential proteolysis of insulin-like growth factor binding protein-1 (IGFBP-1) in pregnancy

References

[1] Anime-Nyame N, Hills FA, Sooranna SR, Steer PJ, Johnson MR. A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod. 2000;15: 2215–9.10.1093/humrep/15.10.2215Search in Google Scholar

[2] Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab. 2003;14:176–81.10.1016/S1043-2760(03)00049-3Search in Google Scholar

[3] Chevalier B, Lagarde A, Degrelle H, Belaisch-Allart J, Giraudet P, Gallet JP. Insulin-like growth factor binding protein-1 level in amniotic fluid: correlation with birth weight. Biol Neonate. 1998;73:404–6.10.1159/000014003Search in Google Scholar PubMed

[4] Claussen M, Zapf J, Braulke T. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology. 1994;134:1964–6.10.1210/endo.134.4.7511097Search in Google Scholar PubMed

[5] Coppock HA, White A, Aplin JD, Westwood M. Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1. Biol Reprod. 2004;71:438–43.10.1095/biolreprod.103.023101Search in Google Scholar PubMed

[6] Davies SC, Holly JMP, Coulson VJ, Cotterill AM, Abdulla AF, Whittacker PG, et al. The presence of cation-dependent proteases for insulin-like growth factor binding proteins (IGFBPs) does not alter the size distribution of insulin-like growth factors in pregnancy. Clin Endocrinol. 1991;34:501–6.10.1111/j.1365-2265.1991.tb00331.xSearch in Google Scholar PubMed

[7] Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23:824–54.10.1210/er.2001-0033Search in Google Scholar PubMed

[8] Frost VJ, Macaulay VM, Wass JA, Holly JM. Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. J Endocrinol. 1993;138:545–54.10.1677/joe.0.1380545Search in Google Scholar PubMed

[9] Gibson JM, Aplin JD, White A, Westwood M. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod. 2001;7:79–87.10.1093/molehr/7.1.79Search in Google Scholar PubMed

[10] Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the peurperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 1990;71:806–16.10.1210/jcem-71-4-806Search in Google Scholar PubMed

[11] Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 1997;176:751–7.10.1016/S0002-9378(97)70598-2Search in Google Scholar

[12] Han VKM, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81:2680–93.Search in Google Scholar

[13] Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol. 1996;148:303–9.10.1677/joe.0.1480303Search in Google Scholar

[14] Holmes RP, Holly JMP, Soothill PW. Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth. Hum Reprod. 1999;14:1479–84.10.1093/humrep/14.7.1879Search in Google Scholar

[15] Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Bionoux M. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the “150 K” complex during pregnancy. J Clin Endocrinol Metab. 1990;71:797–805.10.1210/jcem-71-4-797Search in Google Scholar

[16] Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev. 1999;20:761–87.Search in Google Scholar

[17] Irwin JC, Suen LF, Cheng BH, Martin R, Cannon P, Deal CL, et al. Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology. 2000;141:666–74.10.1210/endo.141.2.7292Search in Google Scholar

[18] Kalus W, Zweckstetter M, Renner C, Sanchez Y, Georgescu J, Grol M, et al. Structure of the IGF-binding domain of the insulin-like growth factor binding protein-5 (IGFBP-5: implications for IGF and IGF-I receptor interactions). EMBO J. 1998;17:6558–72.10.1093/emboj/17.22.6558Search in Google Scholar

[19] Kobayashi H, Suzuki K, Sugino D, Terao T. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol. 1999;180:141–7.10.1016/S0002-9378(99)70164-XSearch in Google Scholar

[20] Lamson G, Giudice LC, Rosenfeld RG. A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab. 1991;72:1391–3.10.1210/jcem-72-6-1391Search in Google Scholar PubMed

[21] Laroche D, Herlicoviez M, Pasquet C, Travert G, Fernandez Y. Amniotic fluid immunoreactive trypsin in pregnancies with normal and pathological outcomes. Acta Obstet Gynecol Scand. 1987;66:587–90.10.3109/00016348709022061Search in Google Scholar PubMed

[22] Lassare C, Binoux M. Insulin-like growth factor binding protein-3 is functionally altered during pregnancy. Endocrinology. 1994;134:1254–62.10.1210/endo.134.3.7509737Search in Google Scholar PubMed

[23] Lee SE, Han BD, Park IS, Romero R, Yoon BH. Evidence supporting proteolytic cleavage of insulin-like growth factor binding protein-1 (IGFBP-1) protein in amniotic fluid. J Perinat Med. 2008;36:316–23.10.1515/JPM.2008.067Search in Google Scholar

[24] Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun. 2000;278:511–5.10.1006/bbrc.2000.3835Search in Google Scholar

[25] Maile LA, Holly JMP. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res. 1999;9:85–95.10.1054/ghir.1999.0096Search in Google Scholar

[26] Neumann GM, Bach LA. The N-terminal disulphide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry. J Biol Chem. 1999;274:14587–94.10.1074/jbc.274.21.14587Search in Google Scholar

[27] Nunn SE, Peehl DM, Cohen P. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma. J Cell Physiol. 1997;171:196–204.10.1002/(SICI)1097-4652(199705)171:2<196::AID-JCP10>3.0.CO;2-CSearch in Google Scholar

[28] Okajima T, Iwashita M, Takeda Y, Sakamoto S, Tanabe T, Yasuda T, et al. Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts. J Endocrinol. 2003;136:457–70.10.1677/joe.0.1360457Search in Google Scholar

[29] Pocknee RC, Abramovich DR. Origin and levels of trypsin in amniotic fluid throughout pregnancy. Br J Obstet Gynaecol. 1982;89:142–4.10.1111/j.1471-0528.1982.tb04681.xSearch in Google Scholar

[30] Robinson PG, Smith PA, Elliott RB. A simple method for the quantitative determination of stool trypsin and chymotrypsin. Clin Chim Acta. 1975;62:225–9.10.1016/0009-8981(75)90231-4Search in Google Scholar

[31] Rutanen EM, Karkkainen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta. 1996;253:91–101.10.1016/0009-8981(96)80001-ESearch in Google Scholar

[32] Rutanen E-M, Koistinen R, Wahlstrom T, Bohn H, Ranta T, Seppala M. Synthesis of placental protein 12 by human decidua. Endocrinology. 1985;116:1304–9.10.1210/endo-116-4-1304Search in Google Scholar

[33] Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia. Prenat Diagn. 2011;31:196–201.10.1002/pd.2682Search in Google Scholar PubMed

[34] Wang HS, Perry LA, Kanisius J, Iles RK, Holly JMP, Chard T. Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. J Endocrinol. 1991;128:161–8.10.1677/joe.0.1280161Search in Google Scholar PubMed